|
Market Cap (17-May) $65,067,412 (361st) |
Close (30-Jun) $0.100 |
Volume (30-Jun) 1,754,344 |
Shortsold (29-Nov) 5,010,077 (0.32%) (345th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -1.3 |
IHL released this announcement to the ASX on 28 February 2023, 9:19. The announcement is marked as price sensitive, and is 5 page(s) in length and 217.14kb in size.
You can view all announcements from IHL and see how they appear on a price chart on the announcements page.
At the date of this announcement, IHL was 2.640% short sold according to ASIC data. It was ranked the 95th most shorted stock on the ASX. It remains ranked 345th as of the latest reported data (29 November 2023).
| Other Recent Announcements from IHL | |
|---|---|
| Change of Director's Interest Notice | 30 June 2023, 13:57 |
| Change of Registered Office | 26 June 2023, 15:51 |
| IHL Announcement - H.C. Wainwright Virtual Conference | 23 June 2023, 8:17 |
| IHL Commences Phase 2 Clinical Trial | 28 February 2023, 9:19 |
| Appendix 4D and Half Year Accounts | 27 February 2023, 11:46 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 27 January 2023, 8:34 |
| Independent data review commences for Ph 2 trial psilocybin | 18 January 2023, 8:25 |
You must be logged in to post a reply.
Incannex Healthcare 